Several factors predict the achievement of the patient acceptable symptom state and minimal clinically important difference for patient‐reported outcome measures following anterior cruciate ligament reconstruction: A systematic review

Abstract

AbstractPurposeTo summarize the predictors of the patient acceptable symptom state (PASS), minimal clinically important difference (MCID) and minimal important change (MIC) for patient‐reported outcome measures (PROMs) following anterior cruciate ligament reconstruction (ACLR).MethodsMEDLINE, PubMed and Embase were searched from inception to 5 January 2024. The authors adhered to PRISMA/R‐AMSTAR guidelines, and the Cochrane Handbook for Systematic Reviews of Interventions. Data on statistical associations between predictive factors and PROMs were extracted. Inverse odds ratios (ORs) and confidence intervals (reverse group comparison) were calculated when appropriate to ensure comparative consistency.ResultsThirteen studies comprising 21,235 patients (48.1% female) were included (mean age 29.3 years). Eight studies comprising 3857 patients identified predictors of PASS, including lateral extra‐articular tenodesis (LET) (OR = 11.08, p = 0.01), hamstring tendon (HT) autografts (OR range: 2.02–2.63, p ≤ 0.011), age over 30 (OR range: 1.37–2.28, p ≤ 0.02), male sex (OR range: 1.03–1.32, p ≤ 0.01) and higher pre‐operative PROMs (OR range: 1.04–1.21). Eight studies comprising 18,069 patients identified negative predictors of MCID or MIC, including female sex (OR = 0.93, p = 0.034), absence of HT autografts (OR = 0.70, p < 0.0001), higher pre‐operative PROMs (OR = 0.76‐0.84, p ≤ 0.01), meniscectomy (OR = 0.67, p = 0.014) and collision sports (OR = 0.02–0.60, p ≤ 0.05).ConclusionHigher pre‐operative PROMs, age over 30, male sex, LETs and HT autografts predicted PASS achievement. Lower pre‐operative PROMs, male sex, non‐collision sports, and lack of meniscectomies predicted MCID/MIC achievement. This review provides a comprehensive understanding of the predictors of clinically significant post‐ACLR outcomes, thus improving clinical decision‐making and the management of patient expectations.Level of EvidenceLevel IV.